Company Getein Biotech, Inc

Equities

603387

CNE100002RR9

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
7.71 ^CNY	-0.52%		-0.77%	-29.91%

Apr. 29	Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 29	Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Getein Biotech Inc is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and instruments. Its in vitro diagnostic reagents include Point-of-care Testing (POCT) reagents, chemiluminescence reagents, biochemical reagents, blood cell reagents, hemagglutination reagents and others. Its diagnostic instruments include immunoquantitative analyzer FIA 8000, immunoquantitative analyzer FIA 8600, fluorescence immunoquantitative analyzer Getein 1100, fluorescence immunoquantitative analyzer Getein 1180, automatic biochemical analyzer CM 400, automatic chemiluminescence analyzer MAGICL 6000 and five classification blood cell analyzer BHA-5000, among others. The Company also provides testing and agency services. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 2,508

CNY in Million	2022	Weight	2023	Weight	Delta
In Vitro Diagnosis 100.0 %	1,822	100.0 %	1,369	100.0 %	-24.85%

CNY in Million	2022	Weight	2023	Weight	Delta
China 89.9 %	1,138	62.5 %	1,230	89.9 %	+8.09%
Overseas 10.1 %	684	37.5 %	139	10.1 %	-79.70%

Managers	Title	Age	Since
En Ben Su CEO	Chief Executive Officer	58	02-03-07
Wen Ni DFI	Director of Finance/CFO	41	12-12-31
Gang Zhu BRD	Director/Board Member	38	11-12-31
Ting Ting Kong BRD	Director/Board Member	40	08-04-30
Bin Yan BRD	Director/Board Member	42	09-12-31
Yu Xin Xie IRC	Investor Relations Contact	30	21-12-31
Cong Liu SEC	Corporate Secretary	-	19-04-24

Members of the board	Title	Age	Since
En Ben Su CEO	Chief Executive Officer	58	02-03-07
Bin Yan BRD	Director/Board Member	42	09-12-31
En Kui Su BRD	Director/Board Member	62	01-12-31
Ting Ting Kong BRD	Director/Board Member	40	08-04-30
Jing Li CHM	Chairman	42	08-12-31
Wen Ni DFI	Director of Finance/CFO	41	12-12-31
Ai Di Tao BRD	Director/Board Member	54	20-12-17
Sui Ren Wan BRD	Director/Board Member	71	20-12-17
Wu Zhang BRD	Director/Board Member	36	09-12-31
Gang Zhu BRD	Director/Board Member	38	11-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	507,153,517	266,858,108 ( 52.62 %)	0	52.62 %

Name	Equities	%	Valuation
En Ben Su 43.23 %	219,218,114	43.23 %	234 M ¥
GF Fund Management Co., Ltd. 0.8837 %	4,481,600	0.8837 %	5 M ¥
En Kui Su 0.8475 %	4,298,283	0.8475 %	5 M ¥
Maxwealth Fund Management Co., Ltd. 0.1995 %	1,011,872	0.1995 %	1 M ¥
Wanjia Asset Management Co., Ltd. 0.1936 %	982,048	0.1936 %	1 M ¥
Gfund Management Co., Ltd. 0.1520 %	771,008	0.1520 %	823 421 ¥
Truvalue Asset Management Co. Ltd. 0.1471 %	745,852	0.1471 %	796 555 ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 0.1319 %	668,900	0.1319 %	714 372 ¥
Ting Ting Kong 0.1240 %	629,042	0.1240 %	671 804 ¥
Zhong Ou Asset Management Co., Ltd 0.0771 %	390,800	0.0771 %	417 367 ¥

Getein Biotech, Inc.

9 Bofu Road Yanjiang Industrial Dev Zone

211505, Nanjing

+86 25 6856 8588

http://www.bio-gp.com.cn

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GETEIN BIOTECH, INC	-29.91%	539M
BIOMÉRIEUX	-4.72%	12.35B
LANTHEUS HOLDINGS, INC.	+99.06%	8.55B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-22.10%	6.6B
DIASORIN S.P.A.	+8.48%	5.88B
AUTOBIO DIAGNOSTICS CO., LTD.	-22.96%	3.52B
ANDON HEALTH CO., LTD.	+6.08%	2.55B
MYRIAD GENETICS, INC.	+38.04%	2.39B
VITROLIFE AB	-7.04%	2.33B
10X GENOMICS, INC.	-68.75%	2.09B

Diagnostic & Testing Substances